To the Editor: Becker et al. recently reported the probable implication of Kytococcus
schroeteri in a case of acute prosthetic valve endocarditis, on the basis of its recovery
from blood cultures drawn at the time of infection (
1
). K. schroeteri was only characterized on that occasion and is a new micrococcal
species resistant to penicillins (
2
). Here, we report the isolation of this organism from prosthetic valve vegetations
in a patient who had undergone aortic valve replacement 3 years earlier. The 73-year-old
man was admitted with fever (38.8°C) and shortness of breath, which had both increased
gradually over the previous 2 months. He had no recent history of intravenous drug
administration or catheterization. Laboratory findings showed a leukocyte count of
12 x 109/L (90% neutrophils) and a raised C-reactive protein level. Transesophageal
echocardiogram revealed several small vegetations on the Carpentier-Edwards aortic
bioprosthesis and a voluminous perivalvular abscess. Four sets of blood cultures were
drawn before antimicrobial therapy was inititiated.
Intravenous vancomycin (2 g twice a day) and gentamicin (240 mg/d) were started empirically.
The prosthetic material was replaced promptly and the abscess was debrided extensively.
Vegetations from the resected material showed numerous polymorphonuclear neutrophils
and gram-positive cocci on microscopic examination. Oral rifampicin (600 mg twice
a day) was added to the initial regimen.
The postoperative course was uneventful except for cutaneous intolerance to vancomycin,
which was replaced with teicoplanin. The physical condition of the patient improved
steadily. Gentamicin and rifampicin were discontinued after 3 weeks. Eight months
after completion of the 6-week treatment, the patient had no clinical or biologic
evidence of infection, although moderate aortic incompetence persisted.
All blood cultures drawn on admission grew gram-positive cocci after 72 hours and
subcultures on Trypticase soy agar yielded convex, muddy–yellow colonies of heterogeneous
sizes. The vegetations, pus samples of the abscess, and prosthetic valve cultures
grew the same type of colonies. All isolates displayed identical biotype and antimicrobial
susceptibility and were considered as a single strain. The causative organism (designated
ROG140) was initially identified as Micrococcus sp. based on the morphologic features,
resistance to nitrofurantoin, and inability to grow anaerobically. Assignment to the
genus Kytococcus was suggested by the arginine dihydrolase activity and resistance
to oxacillin, 2 characteristics that are not shared by other micrococci (
3
).
The definitive K. schroeteri identification was provided by analysis of the fatty
acid content, which was similar to that of the type strain (
2
), and sequencing of the 16S rRNA genes. We sequenced a 1,012-bp fragment encompassing
the first two thirds of the 16S rDNA of ROG140 (accession no. AY692224). The sequence
was compared with type strains of all members of the former genus Micrococcus, and
a phylogenetic tree was deduced by the neighbor–joining method (Figure). The sequences
of ROG140 and the K. schroeteri type strain only differ by an A-to-G substitution
at position 747 (E. coli numbering). Among the 21 nucleotide differences between the
sequences of K. schroeteri and the closely related species K. sedentarius, 10 are
located on a 30-base stretch and constitute a convenient K. schroeteri signature (Figure)
Figure
(A) Phylogenetic tree showing relationships among 16S rDNA sequences of clinical isolate
ROG140 and type strains of members of the former Micrococcus genus. Nocardia asteroides
was included as an out-group organism. The scale bar represents 1% differences in
nucleotide sequences. (B) Sequence alignment of 16S rDNA nucleotides 983-992 and 1003-1014
of Kytococcus sp. type strains (TS) and clinical isolate ROG140. K. schroeteri molecular
signatures are boxed. Nucleotide numbering refers to the sequence of the 16S rDNA
of E. coli.
Antimicrobial susceptibility testing performed with the disk diffusion method and
E-tests (AB Biodisk, Solna, Sweden) indicated that the isolate was resistant to penicillins,
cephalosporins, kanamycin, tobramycin, erythromycin, clindamycin, sulfonamides, and
fusidic acid, but susceptible to imipenem (MIC, 0.25 μg/mL), gentamicin (MIC, 1 μg/mL),
trimethoprim (MIC, 0.25 μg/mL), tetracycline (MIC, 0.12 μg/mL), linezolid (MIC, 0.25
μg/mL), vancomycin (MIC, 0.125 μg/mL), teicoplanin (MIC, 0.06 μg/mL), and rifampicin
(MIC, <0.002 μg/mL). Unlike the original isolate reported by Becker et al. (
1
), isolate ROG140 was resistant to ofloxacin and ciprofloxacin (MICs, 8 μg/mL). Conversely,
moxifloxacin displayed excellent in vitro activity (MIC, 0.05 μg/mL). As moxifloxacin
was more rapidly microbicidal than vancomycin in an animal model of Staphylococcus
aureus prosthetic valve endocarditis (
4
), it might present a potential advantage against infections caused by K. schroeteri,
especially when the oral route is favored.
The natural habitat of K. schroeteri remains unknown. The only isolates of K.
schroeteri identified so far originated from blood or cardiac material, although Kytococcus
literally means “a coccus from the skin.” Our attempts to recover K. schroeteri from
the mouth, nose, or skin of our patient were unsuccessful. In a recent study, Szczerba
et al. were able to isolate most micrococcal species, including K. sedentarius but
not K. schroeteri, from human skin and mucosa (
5
). However, at that time the authors may not have been aware of this newly described
species. The mode of contamination also remains unclear. In the original description
(
1
), K. schroeteri endocarditis had developed in the patient <3 months after she underwent
cardiac surgery, which suggested perioperative contamination. Here, we describe a
late onset, subacute infection 3 years after surgery, which is more likely to have
been caused by hematogenous spread.
Although Micrococcus-like organisms cause endocarditis infrequently (
6
), the description of 2 independent infections due to a new species in a short period
is intriguing and suggests a specific pathogenicity, at least on prosthetic heart
devices. By demonstrating the presence of the bacteria in the infected site, this
report establishes K.
schroeteri as a genuine pathogen in this clinical setting and should prompt further
investigations to identify its natural habitat and virulence determinants. At present,
commercial systems are not able to identify K. schroeteri. However, gram-positive
cocci that are strictly aerobic, oxacillin-resistant, and arginine dihydrolase-positive
should be recognized as potential Kytococcus species and taken into account when endocarditis
is suspected.